{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T10:29:34Z","timestamp":1766226574947,"version":"3.48.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,20]]},"DOI":"10.7759\/cureus.99682","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T10:26:06Z","timestamp":1766226366000},"source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and Patterns of Dyslipidemia Among Patients With Rheumatoid Arthritis: A Retrospective Cohort Study"],"prefix":"10.7759","author":[{"given":"Muna M","family":"Aldhuhoori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibtehal","family":"Makki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Alnuaimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Lootah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/life11101042","article-title":"Ischemic heart disease and rheumatoid arthritis-two conditions, the same background","volume":"11","author":"Rezu\u0219 E","year":"2021","unstructured":"Rezu\u0219 E, Macovei LA, Burlui AM, Cardoneanu A, Rezu\u0219 C. Ischemic heart disease and rheumatoid arthritis-two conditions, the same background. Life (Basel). 2021, 11:1042. 10.3390\/life11101042","journal-title":"Life (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen JS","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016, 388:2023-38. 10.1016\/S0140-6736(16)30173-8","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11102704","article-title":"Cardiovascular disease risk in rheumatoid arthritis anno 2022","volume":"11","author":"Dijkshoorn B","year":"2022","unstructured":"Dijkshoorn B, Raadsen R, Nurmohamed MT. Cardiovascular disease risk in rheumatoid arthritis anno 2022. J Clin Med. 2022, 11:2704. 10.3390\/jcm11102704","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2019-215920","article-title":"Global, regional and national burden of rheumatoid arthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017","volume":"78","author":"Safiri S","year":"2019","unstructured":"Safiri S, Kolahi AA, Hoy D, et al.. Global, regional and national burden of rheumatoid arthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017. Ann Rheum Dis. 2019, 78:1463-71.","journal-title":"Ann Rheum Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-024-02033-z","article-title":"The association between remnant cholesterol and rheumatoid arthritis: insights from a large population study","volume":"23","author":"Yan Y","year":"2024","unstructured":"Yan Y, La R, Jiang M, et al.. The association between remnant cholesterol and rheumatoid arthritis: insights from a large population study. Lipids Health Dis. 2024, 23:38. 10.1186\/s12944-024-02033-z","journal-title":"Lipids Health Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3182290dbf","article-title":"The relationship between carotid intima-media thickness and the activity of rheumatoid arthritis","volume":"17","author":"Targo\u0144ska-Stepniak B","year":"2011","unstructured":"Targo\u0144ska-Stepniak B, Drelich-Zbroja A, Majdan M. The relationship between carotid intima-media thickness and the activity of rheumatoid arthritis. J Clin Rheumatol. 2011, 17:249-55. 10.1097\/RHU.0b013e3182290dbf","journal-title":"J Clin Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/785946","article-title":"Atherogenic index and high-density lipoprotein cholesterol as cardiovascular risk determinants in rheumatoid arthritis: the impact of therapy with biologicals","volume":"2012","author":"Popa CD","year":"2012","unstructured":"Popa CD, Arts E, Fransen J, van Riel PL. Atherogenic index and high-density lipoprotein cholesterol as cardiovascular risk determinants in rheumatoid arthritis: the impact of therapy with biologicals. Mediators Inflamm. 2012, 2012:785946. 10.1155\/2012\/785946","journal-title":"Mediators Inflamm"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.31138\/mjr.310824.cri","article-title":"Cardiovascular risk in rheumatoid arthritis: considerations on assessment and management","volume":"35","author":"Anyfanti P","year":"2024","unstructured":"Anyfanti P, Ainatzoglou A, Angeloudi E, et al.. Cardiovascular risk in rheumatoid arthritis: considerations on assessment and management. Mediterr J Rheumatol. 2024, 35:402-10. 10.31138\/mjr.310824.cri","journal-title":"Mediterr J Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/life13020319","article-title":"Cardiovascular risk assessment in rheumatoid arthritis: accelerated atherosclerosis, new biomarkers, and the effects of biological therapy","volume":"13","author":"Popescu D","year":"2023","unstructured":"Popescu D, Rezus E, Badescu MC, Dima N, Seritean Isac PN, Dragoi IT, Rezus C. Cardiovascular risk assessment in rheumatoid arthritis: accelerated atherosclerosis, new biomarkers, and the effects of biological therapy. Life (Basel). 2023, 13:319. 10.3390\/life13020319","journal-title":"Life (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.12997\/jla.2021.10.2.184","article-title":"Immunologic aspects of dyslipidemia: a critical regulator of adaptive immunity and immune disorders","volume":"10","author":"Kim D","year":"2021","unstructured":"Kim D, Chung H, Lee JE, Kim J, Hwang J, Chung Y. Immunologic aspects of dyslipidemia: a critical regulator of adaptive immunity and immune disorders. J Lipid Atheroscler. 2021, 10:184-201. 10.12997\/jla.2021.10.2.184","journal-title":"J Lipid Atheroscler"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/ar1952","article-title":"Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment - a prospective, controlled study","volume":"8","author":"Georgiadis AN","year":"2006","unstructured":"Georgiadis AN, Papavasiliou EC, Lourida ES, Alamanos Y, Kostara C, Tselepis AD, Drosos AA. Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment - a prospective, controlled study. Arthritis Res Ther. 2006, 8:R82. 10.1186\/ar1952","journal-title":"Arthritis Res Ther"},{"key":"ref12","article-title":"Atherogenic lipid profiles and its management in patients with rheumatoid arthritis","volume":"3","author":"Nurmohamed MT","year":"2007","unstructured":"Nurmohamed MT. Atherogenic lipid profiles and its management in patients with rheumatoid arthritis. Vasc Health Risk Manag. 2007, 3:845-52.","journal-title":"Vasc Health Risk Manag"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1254753","article-title":"Dyslipidemia in rheumatoid arthritis: the possible mechanisms","volume":"14","author":"Yan J","year":"2023","unstructured":"Yan J, Yang S, Han L, et al.. Dyslipidemia in rheumatoid arthritis: the possible mechanisms. Front Immunol. 2023, 14:1254753. 10.3389\/fimmu.2023.1254753","journal-title":"Front Immunol"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2024.07.016","article-title":"Exploring cardiovascular risk factors and atherosclerosis in rheumatoid arthritis","volume":"128","author":"Drosos AA","year":"2024","unstructured":"Drosos AA, Venetsanopoulou AA, Pelechas E, Voulgari PV. Exploring cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Eur J Intern Med. 2024, 128:1-9.","journal-title":"Eur J Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0559-8","article-title":"Significant effects of biologic therapy on lipid profiles and insulin resistance in patients with rheumatoid arthritis","volume":"17","author":"Chen DY","year":"2015","unstructured":"Chen DY, Chen YM, Hsieh TY, Hsieh CW, Lin CC, Lan JL. Significant effects of biologic therapy on lipid profiles and insulin resistance in patients with rheumatoid arthritis. Arthritis Res Ther. 2015, 17:52. 10.1186\/s13075-015-0559-8","journal-title":"Arthritis Res Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach F","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, et al.. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020, 41:111-88. 10.1093\/eurheartj\/ehz455","journal-title":"Eur Heart J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1351.019","article-title":"Epidemiological aspects of rheumatoid arthritis: the sex ratio","volume":"1069","author":"Kvien TK","year":"2006","unstructured":"Kvien TK, Uhlig T, \u00d8deg\u00e5rd S, Heiberg MS. Epidemiological aspects of rheumatoid arthritis: the sex ratio. Ann N Y Acad Sci. 2006, 1069:212-22. 10.1196\/annals.1351.019","journal-title":"Ann N Y Acad Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200367","article-title":"The prevalence of rheumatoid arthritis: a systematic review of population-based studies","volume":"48","author":"Almutairi KB","year":"2021","unstructured":"Almutairi KB, Nossent JC, Preen DB, Keen HI, Inderjeeth CA. The prevalence of rheumatoid arthritis: a systematic review of population-based studies. J Rheumatol. 2021, 48:669-76. 10.3899\/jrheum.200367","journal-title":"J Rheumatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003785","article-title":"When does obesity exert its effect in conferring risk of developing RA: a large study in cohorts of symptomatic persons at risk","volume":"10","author":"Dumoulin QA","year":"2024","unstructured":"Dumoulin QA, Boeren AM, Krijbolder DI, et al.. When does obesity exert its effect in conferring risk of developing RA: a large study in cohorts of symptomatic persons at risk. RMD Open. 2024, 10:e003785. 10.1136\/rmdopen-2023-003785","journal-title":"RMD Open"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.122374","article-title":"Total cholesterol and LDL levels decrease before rheumatoid arthritis","volume":"69","author":"Myasoedova E","year":"2010","unstructured":"Myasoedova E, Crowson CS, Kremers HM, Fitz-Gibbon PD, Therneau TM, Gabriel SE. Total cholesterol and LDL levels decrease before rheumatoid arthritis. Ann Rheum Dis. 2010, 69:1310-4. 10.1136\/ard.2009.122374","journal-title":"Ann Rheum Dis"},{"key":"ref21","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-015-0804-1","article-title":"High serum cholesterol predicts rheumatoid arthritis in women, but not in men: a prospective study","volume":"17","author":"Turesson C","year":"2015","unstructured":"Turesson C, Bergstr\u00f6m U, Pikwer M, Nilsson J\u00c5, Jacobsson LT. High serum cholesterol predicts rheumatoid arthritis in women, but not in men: a prospective study. Arthritis Res Ther. 2015, 17:284.","journal-title":"Arthritis Res Ther"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4274\/hamidiyemedj.galenos.2024.07088","article-title":"Impact of anti-tumor necrosis factor alpha treatment on lipid profile in patients with rheumatoid arthritis","volume":"5","author":"\u00c7ekin R","year":"2024","unstructured":"\u00c7ekin R, Ol\u00e7um GG. Impact of anti-tumor necrosis factor alpha treatment on lipid profile in patients with rheumatoid arthritis. Hamidiye Med J. 2024, 5:91-6. 10.4274\/hamidiyemedj.galenos.2024.07088","journal-title":"Hamidiye Med J"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2023.105683","article-title":"Lipid profile and NT-proBNP changes from pre-clinical to established rheumatoid arthritis: a 12 years follow-up explorative study","volume":"91","author":"Raadsen R","year":"2024","unstructured":"Raadsen R, Dijkshoorn B, van Boheemen L, Ten Boekel E, van Kuijk AW, Nurmohamed MT. Lipid profile and NT-proBNP changes from pre-clinical to established rheumatoid arthritis: a 12 years follow-up explorative study. Joint Bone Spine. 2024, 91:105683. 10.1016\/j.jbspin.2023.105683","journal-title":"Joint Bone Spine"},{"key":"ref24","article-title":"Dislipidemia in patients with rheumatoid arthritis treated with synthetic DMARDs","volume":"3","author":"Kholmirzayev B","year":"2025","unstructured":"Kholmirzayev B. Dislipidemia in patients with rheumatoid arthritis treated with synthetic DMARDs. Front Global Sci. 2025, 3:24-7.","journal-title":"Front Global Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1190607","article-title":"Lipid metabolism and rheumatoid arthritis","volume":"14","author":"Lei Q","year":"2023","unstructured":"Lei Q, Yang J, Li L, Zhao N, Lu C, Lu A, He X. Lipid metabolism and rheumatoid arthritis. Front Immunol. 2023, 14:1190607. 10.3389\/fimmu.2023.1190607","journal-title":"Front Immunol"},{"key":"ref26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-086116","article-title":"Prevalence of comorbidities among patients with rheumatoid arthritis in the UAE: a case-control study","volume":"14","author":"Al-Saleh J","year":"2024","unstructured":"Al-Saleh J, Ali Khan N, Zamani N, AlSaidi H, Rachidi W. Prevalence of comorbidities among patients with rheumatoid arthritis in the UAE: a case-control study. BMJ Open. 2024, 14:e086116.","journal-title":"BMJ Open"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen JS","year":"2023","unstructured":"Smolen JS, Landew\u00e9 RB, Bergstra SA, et al.. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis. 2023, 82:3-18. 10.1136\/ard-2022-223356","journal-title":"Ann Rheum Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1146261","article-title":"Rheumatoid arthritis and hypothyroidism: a bidirectional Mendelian randomization study","volume":"14","author":"Duan L","year":"2023","unstructured":"Duan L, Chen D, Shi Y, Ye S, Dou S, Feng Y. Rheumatoid arthritis and hypothyroidism: a bidirectional Mendelian randomization study. Front Immunol. 2023, 14:1146261. 10.3389\/fimmu.2023.1146261","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/439629-prevalence-and-patterns-of-dyslipidemia-among-patients-with-rheumatoid-arthritis-a-retrospective-cohort-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T10:26:08Z","timestamp":1766226368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/439629-prevalence-and-patterns-of-dyslipidemia-among-patients-with-rheumatoid-arthritis-a-retrospective-cohort-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.99682","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,20]]}}}